Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study). (Record no. 26734475)

MARC details
000 -LEADER
fixed length control field 02527 a2200709 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517132150.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201710s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1463-1326
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/dom.12866
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ahn, Chang Ho
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20171010
245 00 - TITLE STATEMENT
Title Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study).
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Diabetes, obesity & metabolism
Date of publication, distribution, etc. 05 2017
300 ## - PHYSICAL DESCRIPTION
Extent 635-643 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 2
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dipeptidyl-Peptidase IV Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Monitoring
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glycated Hemoglobin
General subdivision analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hyperglycemia
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypoglycemia
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hypoglycemic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Incidence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Metformin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperidones
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Republic of Korea
General subdivision epidemiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sulfonylurea Compounds
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Han, Kyung Ah
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Yu, Jae Myung
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nam, Joo Young
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ahn, Kyu Jeung
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Oh, Tae Keun
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, Hyoung Woo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, Dae Ho
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kim, Jaetaek
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chung, Choon Hee
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Park, Tae Sun
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kim, Byung Joon
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Park, Seok Won
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Park, Hyeong Kyu
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, Kwang Jae
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kim, Sang-Wook
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Park, Jeong Hyun
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ko, Kwan Pyo
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kim, Chong Hwa
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, Hyunjin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jang, Hak Chul
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Park, Kyong Soo
773 0# - HOST ITEM ENTRY
Title Diabetes, obesity & metabolism
Related parts vol. 19
-- no. 5
-- p. 635-643
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/dom.12866">https://doi.org/10.1111/dom.12866</a>
Public note Available from publisher's website

No items available.